Contact Us
 • 
Home
Search 

Welcome to the Liverpool Cancer Trials Unit Website

The site includes information on the current trials that are being managed by the LCTU, current staff, information on Pancreatic cancer and useful links to other sites.

We hope that you enjoy looking round the site and if you have any queries or suggestions please don't hesitate to contact us using our email address: lctu@liv.ac.uk

For more information on cancer and the trials that are currently running within the UK please visit the Cancer Help Website

NB. All recruitment and site information on the LCTU website is updated in realtime from LCTU data management systems.



Latest News

PPAC Logo

Packing of Perianal Abscess Cavities - full study now in set-up

The Phase III Randomised Controlled Trial assessing the impact of postoperative Packing of Perianal Abscess Cavities in now funded and in set-up.  Packing changes are very painful for patients that have undergone this procedure.  The primary aim of this study is to assess the pain of wound cavity packing changes versus no wound cavity packing at all, as well as the wound cavity healing rate of both techniques as a secondary aim. Other secondary aims will also be assessed.  A .....

NWSTC Investigator awarded RCSEng Fellowship

Congratulations to General Surgeon, Ms Lyndsay Pearce on being awarded the Royal College of Surgeons of England 'Lady Estelle Wolfson Emerging Learners Fellowship'. Lyndsay is an ST8 General Surgeon and is heavily involved with trainee surgical research in the North West region. She is the Chair of the PPAC2 steering committee and is actively involved in numerous nationwide studies that are on the North West Surgical Trials Centre (NWSTC) portfolio, as well as many clinical audits. .....

Cancer Cell

Researchers discover new way to destroy cancer cells

Researchers from Liverpool have identified a new way to kill certain cancer cells – by starving them of a key nutrient. The finding could lead the way in more personalised treatment of certain cancers.

In a paper published in the journal Cell Reports, scientists including Ioannis Poursaitidis and Xiaomeng Wang from the University’s Institute of Translational Medicine and Dr Richard Lamb from Liverpool Hope University, share the results of their .....

New approach improves five-year survival for pancreatic cancer patients

A University of Liverpool led clinical trial has shown that 29% of pancreatic cancer patients given a combination of two chemotherapy drugs lived for at least five years compared with 16% who received the one chemotherapy drug.

The latest Cancer Research UK figures show that around 9,400 people are diagnosed with pancreatic cancer each year in the UK and around 8,800 people die from the disease each year.

The trial involved 732 patients in hospitals across the UK, German, Sweden .....